Coronally the advanced flap is considered a predictable treatment of gingival recession but in certain situations, it needs a filler like subperiosteal connective tissue graft (CTG) which is considered as the gold standard treatment approach. This randomized controlled trial compares the clinical benefits and effectiveness of a xenogenic collagen matrix (mucoderm, botiss, dental, Berlin, Germany) as a filler to the subperiosteal connective tissue graft (CTG).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
24
xenogeneic collagen matrix called mucoderm used for root coverage for treatment of gingival recession instead of harvesting from the patients connective tissue
Assiut University
Asyut, Egypt
The zone of keratinized gingiva
The distance from the tip of the papilla to the mucogingival junction minus the probing depth measured in mm using graduated periodontal probe.
Time frame: 6 months after the surgery
Periodontal probing depth
measured from the gingival margin to the depth of the gingival sulcus in six sites per tooth and measured in mm.
Time frame: 6 months after the surgery
Clinical attachment loss
measured from the cementoenamel junction to the depth of the sulcus in six sites per tooth and measured in mm.
Time frame: 6 months after the surgery
Gingival recession
The depth measured from the gingival margin to the cementoenamel junction in mm.
Time frame: 6 months after the surgery
Patient satisfaction of the esthetics
measured using the visual analog scale.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.